Matches in Nanopublications for { ?s ?p "[Preliminary in vitro and in vivo studies with valproic acid (VPA) in cell lines and patients with spinal muscular atrophy (SMA) demonstrate increased expression of SMN, supporting the possibility of therapeutic benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- assertion description "[Preliminary in vitro and in vivo studies with valproic acid (VPA) in cell lines and patients with spinal muscular atrophy (SMA) demonstrate increased expression of SMN, supporting the possibility of therapeutic benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Preliminary in vitro and in vivo studies with valproic acid (VPA) in cell lines and patients with spinal muscular atrophy (SMA) demonstrate increased expression of SMN, supporting the possibility of therapeutic benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Preliminary in vitro and in vivo studies with valproic acid (VPA) in cell lines and patients with spinal muscular atrophy (SMA) demonstrate increased expression of SMN, supporting the possibility of therapeutic benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Preliminary in vitro and in vivo studies with valproic acid (VPA) in cell lines and patients with spinal muscular atrophy (SMA) demonstrate increased expression of SMN, supporting the possibility of therapeutic benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Preliminary in vitro and in vivo studies with valproic acid (VPA) in cell lines and patients with spinal muscular atrophy (SMA) demonstrate increased expression of SMN, supporting the possibility of therapeutic benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP738838.RAAsb7jqsXi2yJd2XnbEoh79EpvAAY8is-LDCGEuLfgzo130_assertion description "[Preliminary in vitro and in vivo studies with valproic acid (VPA) in cell lines and patients with spinal muscular atrophy (SMA) demonstrate increased expression of SMN, supporting the possibility of therapeutic benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP738838.RAAsb7jqsXi2yJd2XnbEoh79EpvAAY8is-LDCGEuLfgzo130_provenance.
- NP738839.RATdfeYPH8gnSlPKh66RDL3x5H9L_jmkTFGkTFJiQNrHQ130_assertion description "[Preliminary in vitro and in vivo studies with valproic acid (VPA) in cell lines and patients with spinal muscular atrophy (SMA) demonstrate increased expression of SMN, supporting the possibility of therapeutic benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP738839.RATdfeYPH8gnSlPKh66RDL3x5H9L_jmkTFGkTFJiQNrHQ130_provenance.
- NP738840.RAImlRbkNjnOrFzqC5V0AA0GglnwrXCzg5C-kisWxGW0Q130_assertion description "[Preliminary in vitro and in vivo studies with valproic acid (VPA) in cell lines and patients with spinal muscular atrophy (SMA) demonstrate increased expression of SMN, supporting the possibility of therapeutic benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP738840.RAImlRbkNjnOrFzqC5V0AA0GglnwrXCzg5C-kisWxGW0Q130_provenance.
- NP738841.RAK5xGRhC-O773zk0UBFK1pxrS449638eQb7Va4o4TV84130_assertion description "[Preliminary in vitro and in vivo studies with valproic acid (VPA) in cell lines and patients with spinal muscular atrophy (SMA) demonstrate increased expression of SMN, supporting the possibility of therapeutic benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP738841.RAK5xGRhC-O773zk0UBFK1pxrS449638eQb7Va4o4TV84130_provenance.